Dual Frequency Low-Level Laser Therapy in Myofascial Trigger Points of Upper Trapezius
DF-LLLT-MTP-UT
A Randomized Controlled Trial to Evaluate the Effect of Dual Frequency Low-Level Laser Therapy on Pain Intensity, Pressure Pain Threshold, and Functional Outcomes in Patients With Myofascial Trigger Points in the Upper Trapezius Muscle
1 other identifier
interventional
48
1 country
1
Brief Summary
The goal of this clinical trial is to determine whether dual frequency low-level laser therapy can reduce pain, improve function, and increase neck movement in patients with myofascial trigger points in the upper trapezius muscle. The study includes men and women aged 20 to 55 years who have been diagnosed with upper trapezius myofascial pain syndrome. The main questions it aims to answer are:
- Does dual frequency low-level laser therapy reduce pain more effectively than single wavelength laser therapy?
- Does dual frequency low-level laser therapy improve functional ability and cervical range of motion more than other treatments? Researchers compared three groups of participants receiving different treatments to evaluate their effects. Participants were randomly assigned to one of three groups:
- Group A received red wavelength low-level laser therapy with conventional physiotherapy
- Group B received infrared low-level laser therapy with conventional physiotherapy
- Group C received dual frequency low-level laser therapy with conventional physiotherapy All participants received treatment twice weekly for four weeks. Conventional therapy included stretching exercises, strengthening exercises, and postural correction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 2, 2025
CompletedFirst Submitted
Initial submission to the registry
August 15, 2025
CompletedFirst Posted
Study publicly available on registry
August 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 2, 2026
CompletedApril 21, 2026
April 1, 2026
9 months
August 15, 2025
April 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pain Intensity (Visual Analog Scale)
Pain intensity was measured using the Visual Analogue Scale (VAS), a 0-10 scale where higher scores indicate greater pain intensity.
Baseline, Week 2, Week 4
Functional Disability (Neck Disability Index)
Functional disability was assessed using the Neck Disability Index (NDI), which evaluates the impact of neck pain on daily activities.
Baseline, Week 2, Week 4
Cervical Range of Motion
Cervical range of motion (flexion, extension, lateral flexion, and rotation) was measured using a goniometer.
Baseline, Week 2, Week 4
Study Arms (3)
Red Low-Level Laser Therapy
EXPERIMENTALParticipants received red wavelength low-level laser therapy (660 nm) combined with conventional physiotherapy including stretching, strengthening, and postural correction exercises.
Infrared Low-Level Laser Therapy
EXPERIMENTALParticipants received infrared low-level laser therapy (830 nm) combined with conventional physiotherapy.
Dual Frequency Low-Level Laser Therapy
EXPERIMENTALParticipants received dual frequency low-level laser therapy (660 nm and 830 nm) combined with conventional physiotherapy.
Interventions
Dual frequency laser therapy combining red (660 nm) and infrared (830 nm) wavelengths was applied sequentially to trigger points with a dose of 5 J/cm² per wavelength, twice weekly for four weeks.
Red wavelength (660 nm) low-level laser therapy was applied to upper trapezius trigger points at a dose of 5 J/cm², frequency 9-10 Hz, for 60-100 seconds per point, twice weekly for four weeks.
Infrared wavelength (830 nm) low-level laser therapy was applied to trigger points at a dose of 5 J/cm² for approximately 3 minutes per point, twice weekly for four weeks.
Conventional physiotherapy included stretching exercises, isometric strengthening, and postural correction techniques.
Eligibility Criteria
You may qualify if:
- Men and women aged 20-55 years.
- Diagnosis of myofascial pain based on Simons criteria.
- At least two trigger points in the upper trapezius muscle.
- Pain duration ≥ 3 months.
- VAS pain score ≥ 5.
- Limited cervical range of motion (40-60%) due to trigger points.
You may not qualify if:
- Pregnancy.
- Use of anticoagulants.
- Bleeding disorders or dermatological diseases at treatment site.
- History of infectious, inflammatory, tumoral, cardiopulmonary, psychiatric, or systemic diseases.
- Kellgren stage 3-4 cervical osteoarthritis or cervical disc herniation causing radiculopathy.
- Diagnosis of fibromyalgia.
- Inability to follow instructions or complete questionnaires.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MoveNow Physiotherapy and Rehabilitation Centre
Lahore, Punjab Province, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor was blinded to group allocation to reduce assessment bias.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 15, 2025
First Posted
August 22, 2025
Study Start
June 2, 2025
Primary Completion
February 28, 2026
Study Completion
March 2, 2026
Last Updated
April 21, 2026
Record last verified: 2026-04